InvestorsHub Logo
Followers 0
Posts 94
Boards Moderated 0
Alias Born 05/10/2012

Re: Pepperchino post# 41932

Tuesday, 09/17/2013 11:27:11 AM

Tuesday, September 17, 2013 11:27:11 AM

Post# of 403076
EasyRider,

As I recall, it was also stated by Polymedix that shorter dosing schedules (1-3 days versus 5 days) would limit SAE's. I believe blood serum tests pointed to efficacy in the shorter time frame.

That is a two-headed snake. Shorter dosing regimens mean less chances of SAE's and lower hospitalization costs but can also mean less profit for the manufacturer. Perhaps Cellceutix can overcome that by charging more per dose based on the other potential savings?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News